Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review
Christophe Richez(Centre National de la Recherche Scientifique), A. Marti(Hôpital Saint-André), Patrick Blanco(Centre National de la Recherche Scientifique), Marie‐Elise Truchetet(Centre National de la Recherche Scientifique), Noémie Gensous(Centre National de la Recherche Scientifique), Thomas Barnetche(Université de Bordeaux), Estibaliz Lazaro(Centre National de la Recherche Scientifique), P. Duffau(Centre National de la Recherche Scientifique), Julien Sénéschal(Hôpital Saint-André)
Cited by 92
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study
|Annals of the Rheumatic Diseases|2017|302
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|261